Afprøvning af virkningerne af træning på kemoterapi-induceret perifer neuropati (CIPN)
Multicenter randomiseret kontrolleret fase II forsøg med træning til behandling af kemoterapi-induceret perifer neuropati (CIPN)
This phase II trial studies whether using exercise is better than the usual approach for treating chemotherapy-induced peripheral neuropathy (CIPN). CIPN occurs when chemotherapy damages the nerves communicating between the brain, spinal cord, and the rest of the body. The usual approach for treating CIPN is treatment with drugs that help reduce symptoms of other types of neuropathy (for example, from diabetes). However, these drugs do not treat all symptoms of CIPN. Exercise may help to reduce CIPN symptoms.
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Detaljeret beskrivelse
PRIMARY OBJECTIVE:
I. Assess the preliminary efficacy of exercise versus (vs.) standard care for treating CIPN (via patient-reported CIPN-20 total score).
SECONDARY OBJECTIVES:
I. Assess the preliminary efficacy of exercise vs. standard care on individual symptoms of CIPN (via CIPN Symptom Inventory; i.e., numbness, tingling, burning/shooting pain, and cramping in the hands and feet).
II. Assess the preliminary efficacy of exercise vs. standard care on a clinical test of CIPN symptoms (via the tactile sensitivity in the fingers and toes).
III. Assess the effects of exercise vs. standard care on two possible CIPN mechanisms, namely interoception (via Multidimensional Assessment of Interoceptive Awareness version 2 [MAIA-2] questionnaire).
EXPLORATORY OBJECTIVES:
I. Assess the effects of exercise vs. standard care on other common symptoms related to cancer, chemotherapy, and CIPN, including:
Ia. Daily Diary of symptoms of CIPN. Ib. An array of cancer and treatment symptoms (MD Anderson Symptom Inventory; MDASI).
Ic. Anxiety and depression (hospital anxiety and depression scale; HADS). Id. Pain catastrophizing (pain catastrophizing scale; PCS). Ie. Cognitive impairment (Functional Assessment of Cancer Therapy-Cognitive [FACT-Cog]).
If. Fatigue (brief fatigue inventory; BFI). Ig. Quality of life (Functional Assessment of Cancer Therapy - General [FACT-G]).
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM 1 (EXERCISE): Participants undergo the exercise for cancer patients (EXCAP) intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5.
ARM 2 (CONTROL): Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes.
Participants may optionally undergo magnetic resonance imaging (MRI) on study.
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Fresno, California, Forenede Stater, 93720
- Kaiser Permanente-Fresno
-
Martinez, California, Forenede Stater, 94553-3156
- Contra Costa Regional Medical Center
-
Roseville, California, Forenede Stater, 95661
- Kaiser Permanente-Roseville
-
Sacramento, California, Forenede Stater, 95814
- Kaiser Permanente Downtown Commons
-
Sacramento, California, Forenede Stater, 95823
- Kaiser Permanente-South Sacramento
-
San Jose, California, Forenede Stater, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Leandro, California, Forenede Stater, 94577
- Kaiser Permanente San Leandro
-
San Rafael, California, Forenede Stater, 94903
- Kaiser San Rafael-Gallinas
-
Santa Clara, California, Forenede Stater, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
South San Francisco, California, Forenede Stater, 94080
- Kaiser Permanente-South San Francisco
-
Vallejo, California, Forenede Stater, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Forenede Stater, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Forenede Stater, 80012
- Rocky Mountain Cancer Centers-Aurora
-
Boulder, Colorado, Forenede Stater, 80303
- Boulder Community Foothills Hospital
-
Boulder, Colorado, Forenede Stater, 80304
- Rocky Mountain Cancer Centers-Boulder
-
Centennial, Colorado, Forenede Stater, 80112
- Rocky Mountain Cancer Centers - Centennial
-
Denver, Colorado, Forenede Stater, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Forenede Stater, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Forenede Stater, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Forenede Stater, 80209
- The Women's Imaging Center
-
Englewood, Colorado, Forenede Stater, 80113
- Rocky Mountain Cancer Centers - Swedish
-
Englewood, Colorado, Forenede Stater, 80113
- The Melanoma and Skin Cancer Institute
-
Lakewood, Colorado, Forenede Stater, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Littleton, Colorado, Forenede Stater, 80120
- Rocky Mountain Cancer Centers-Littleton
-
Lone Tree, Colorado, Forenede Stater, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, Forenede Stater, 80501
- Rocky Mountain Cancer Centers-Longmont
-
Thornton, Colorado, Forenede Stater, 80260
- Rocky Mountain Cancer Centers-Thornton
-
-
Delaware
-
Millville, Delaware, Forenede Stater, 19967
- Beebe South Coastal Health Campus
-
Newark, Delaware, Forenede Stater, 19713
- Helen F Graham Cancer Center
-
Newark, Delaware, Forenede Stater, 19713
- Medical Oncology Hematology Consultants PA
-
Rehoboth Beach, Delaware, Forenede Stater, 19971
- Beebe Health Campus
-
-
District of Columbia
-
Washington D.C., District of Columbia, Forenede Stater, 20010
- MedStar Washington Hospital Center
-
Washington D.C., District of Columbia, Forenede Stater, 20007
- MedStar Georgetown University Hospital
-
-
Hawaii
-
Honolulu, Hawaii, Forenede Stater, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Forenede Stater, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Forenede Stater, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Forenede Stater, 96826
- Kapiolani Medical Center for Women and Children
-
‘Aiea, Hawaii, Forenede Stater, 96701
- Hawaii Cancer Care - Westridge
-
‘Aiea, Hawaii, Forenede Stater, 96701
- Pali Momi Medical Center
-
-
Illinois
-
Carterville, Illinois, Forenede Stater, 62918
- SIH Cancer Institute
-
Centralia, Illinois, Forenede Stater, 62801
- Centralia Oncology Clinic
-
Danville, Illinois, Forenede Stater, 61832
- Carle at The Riverfront
-
Decatur, Illinois, Forenede Stater, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Forenede Stater, 62526
- Cancer Care Specialists of Illinois - Decatur
-
Effingham, Illinois, Forenede Stater, 62401
- Crossroads Cancer Center
-
O'Fallon, Illinois, Forenede Stater, 62269
- Cancer Care Center of O'Fallon
-
Urbana, Illinois, Forenede Stater, 61801
- Carle Cancer Center
-
-
Iowa
-
Cedar Rapids, Iowa, Forenede Stater, 52403
- Oncology Associates at Mercy Medical Center
-
Cedar Rapids, Iowa, Forenede Stater, 52402
- Physicians' Clinic of Iowa PC
-
Des Moines, Iowa, Forenede Stater, 50314
- Mercy Medical Center - Des Moines
-
-
Maryland
-
Elkton, Maryland, Forenede Stater, 21921
- Christiana Care - Union Hospital
-
-
Michigan
-
Ann Arbor, Michigan, Forenede Stater, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Brighton, Michigan, Forenede Stater, 48114
- Trinity Health IHA Medical Group Hematology Oncology - Brighton
-
Brighton, Michigan, Forenede Stater, 48114
- Trinity Health Medical Center - Brighton
-
Canton, Michigan, Forenede Stater, 48188
- Trinity Health IHA Medical Group Hematology Oncology - Canton
-
Canton, Michigan, Forenede Stater, 48188
- Trinity Health Medical Center - Canton
-
Chelsea, Michigan, Forenede Stater, 48118
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital
-
Chelsea, Michigan, Forenede Stater, 48118
- Chelsea Hospital
-
Grand Rapids, Michigan, Forenede Stater, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Lansing, Michigan, Forenede Stater, 48912
- University of Michigan Health - Sparrow Lansing
-
Livonia, Michigan, Forenede Stater, 48154
- Trinity Health Saint Mary Mercy Livonia Hospital
-
Ypsilanti, Michigan, Forenede Stater, 48197
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus
-
-
Minnesota
-
Coon Rapids, Minnesota, Forenede Stater, 55433
- Mercy Hospital
-
Fridley, Minnesota, Forenede Stater, 55432
- Unity Hospital
-
Minneapolis, Minnesota, Forenede Stater, 55407
- Abbott-Northwestern Hospital
-
Saint Louis Park, Minnesota, Forenede Stater, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Paul, Minnesota, Forenede Stater, 55101
- Regions Hospital
-
Waconia, Minnesota, Forenede Stater, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Forenede Stater, 56201
- Rice Memorial Hospital
-
-
Missouri
-
Osage Beach, Missouri, Forenede Stater, 65065
- Lake Regional Hospital
-
St Louis, Missouri, Forenede Stater, 63131
- Missouri Baptist Medical Center
-
-
North Carolina
-
Gastonia, North Carolina, Forenede Stater, 28054
- CaroMont Regional Medical Center
-
Lincolnton, North Carolina, Forenede Stater, 28092
- CaroMont Health - Lincoln Cancer Center
-
Pinehurst, North Carolina, Forenede Stater, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Rocky Mount, North Carolina, Forenede Stater, 27804
- Nash UNC HealthCare
-
-
Ohio
-
Belpre, Ohio, Forenede Stater, 45714
- Strecker Cancer Center-Belpre
-
Lancaster, Ohio, Forenede Stater, 43130
- Fairfield Medical Center
-
Lima, Ohio, Forenede Stater, 45801
- Saint Rita's Medical Center
-
Marietta, Ohio, Forenede Stater, 45750
- Marietta Memorial Hospital
-
Newark, Ohio, Forenede Stater, 43055
- Licking Memorial Hospital
-
Portsmouth, Ohio, Forenede Stater, 45662
- Southern Ohio Medical Center
-
Zanesville, Ohio, Forenede Stater, 43701
- Genesis Healthcare System Cancer Care Center
-
-
South Carolina
-
Boiling Springs, South Carolina, Forenede Stater, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Easley, South Carolina, Forenede Stater, 29640
- Prisma Health Cancer Institute - Easley
-
Greenville, South Carolina, Forenede Stater, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Forenede Stater, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Forenede Stater, 29605
- Prisma Health Cancer Institute - Butternut
-
Greer, South Carolina, Forenede Stater, 29650
- Prisma Health Cancer Institute - Greer
-
Seneca, South Carolina, Forenede Stater, 29672
- Prisma Health Cancer Institute - Seneca
-
-
Virginia
-
Chesapeake, Virginia, Forenede Stater, 23320
- Chesapeake Regional Medical Center
-
-
Wisconsin
-
Green Bay, Wisconsin, Forenede Stater, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Forenede Stater, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Sturgeon Bay, Wisconsin, Forenede Stater, 54235-1495
- Saint Vincent Hospital Cancer Center at Sturgeon Bay
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Have a diagnosis of cancer
- Have received neurotoxic chemotherapy within the past nine months (could still be on chemotherapy or have already completed chemotherapy; i.e., taxane-, platinum-, vinca alkaloid-, epothilone-, or proteasome inhibitor-based chemotherapy
- Report one or more symptoms of CIPN at a level of >= 4 on the CIPN symptom inventory on the Screening Form
- Have an Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Have at least six months life expectancy
- Be at least 18 years of age
- Be able to read and understand English
- Be able to provide written informed consent
Exclusion Criteria:
- Have physical limitations (e.g., cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in a low to moderate intensity home-based walking and progressive resistance exercise program, according to the participant's physician (e.g., oncologist, primary care) or physician's designee
- Be identified as in the active or maintenance stage of exercise behavior per the Exercise Stages of Change Question on the Screening Form
- Have planned surgery or radiation treatment during the course of the study (hormonal and biologic therapy is allowed)
- Have contraindications for MRI scanning, per the MRI safety screening procedures of the MRI facility to be utilized for this participant
- Are pregnant of have plans to become pregnant during the course of the study. Documentation of pregnancy and use of contraception can be obtained from the medical record.
- Have a current or prior cancer in the central nervous system (spine, brainstem, brain) as this would interfere with assessments of brain functional connectivity.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Enkelt
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Arm 1 (EXCAP, tactile sensitivity test, counseling)
Participants undergo the EXCAP intervention consisting of a home-based, self-directed, individually tailored progressive walking and resistance program for up to 6 weeks. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. In addition, participants meet with a certified exercise instructor over 45 minutes at baseline and 2 additional booster meetings over 15-30 minutes during weeks 2 and 3 or weeks 4 and 5. Participants may optionally undergo MRI on study. |
Undergo MRI
Andre navne:
Ancillary studies Meet with certified exercise instructor Participate in the EXCAP program Undergo tactile sensitivity test
Andre navne:
|
|
Aktiv komparator: Arm 2 (usual care, tactile sensitivity test)
Participants receive usual care for 6 weeks. At the end of the study, participants may receive the exercise kit and complete the EXCAP program as in Arm 1. Participants also undergo a tactile sensitivity test at baseline and after completion of EXCAP over 15-25 minutes. Participants may optionally undergo MRI on study. |
Undergo MRI
Andre navne:
Ancillary studies Meet with certified exercise instructor Participate in the EXCAP program Undergo tactile sensitivity test
Andre navne:
Receive standard of care
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Chemotherapy-induced peripheral neuropathy (CIPN) symptom severity
Tidsramme: Week 6 post randomization
|
Will estimate the effects of exercise versus usual care on CIPN using analysis of covariance (ANCOVA). Will be measured by the mean European Organization for Research and Treatment of Cancer-CIPN20. The model will include CIPN-20 at Week 6 as the outcome, treatment group (exercise vs. usual care) as the independent variable of interest and the pre-intervention CIPN-20 score as a covariate. |
Week 6 post randomization
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Effects of exercise on the severity of CIPN symptoms
Tidsramme: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on CIPN symptoms (i.e., hot/burning or sharp/shooting pain in the hands or feet, numbness or tingling in the hands or feet) collected from the daily symptom inventory (0-10 severity) using analysis of covariance (ANCOVA). The model will include the average of daily symptom inventory for each CIPN symptom at post-intervention as the outcome, controlling for the average of daily symptom inventory for each CIPN symptom at pre-intervention. |
Up to 6 weeks post randomization
|
|
Effects of exercise on tactile sensitivity
Tidsramme: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on tactile sensitivity in the fingers and toes, assessed via an established touch test procedure with a set of monofilaments, using analysis of covariance (ANCOVA). The model will include the tactile sensitivity score at post-intervention as the outcome, controlling for the pre-intervention score. |
Up to 6 weeks post randomization
|
|
Effect of exercise on interoception
Tidsramme: Up to 6 weeks post randomization
|
We will estimate the effects of exercise vs. usual care on interoception, measured via the Multidimensional Assessment of Interoceptive Awareness version 2 (MAIA-2), using analysis of covariance (ANCOVA). The model will include the MAIA-2 total score at post-intervention as the outcome, controlling for the pre-intervention MAIA-2 total score. |
Up to 6 weeks post randomization
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Ian R Kleckner, University of Rochester NCORP Research Base
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Neoplasmer efter sted
- Neoplasmer
- Hæmatologiske sygdomme
- Hemiske og lymfatiske sygdomme
- Hæmatologiske neoplasmer
- Sundhedstjenester Administration
- Sundhedsvæsenets kvalitet, adgang og evaluering
- Undersøgelsesteknikker
- Terapeutik
- Sundhedskvalitet
- Kvalitetsindikatorer, sundhedsvæsenet
- Kemiteknikker, analytisk
- Spektrumanalyse
- Adfærdskontrol
- Immobilisering
- Retningslinjer som emne
- Kvalitetssikring, sundhedsvæsen
- Standard for pleje
- Magnetisk resonansspektroskopi
- Tilbageholdenhed, fysisk
- Øv retningslinjer som emne
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- URCC19075
- UG1CA189961 (U.S. NIH-bevilling/kontrakt)
- URCC19075 (Anden identifikator: University of Rochester NCORP Research Base)
- NCI-2020-11456 (Registry Identifier: CTRP (Clinical Trial Reporting Program))
- URCC-19075 (Anden identifikator: CTEP)
- R21CA256154 (U.S. NIH-bevilling/kontrakt)
- URCC-19075 (Anden identifikator: DCP)
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .